Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients. - Gradman,A.H.; Schmieder,R.E.; Lins,R.L. (Circulation, 2005)